{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:31:18Z","timestamp":1792211478705,"version":"4.4.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Spasticity management should be provided within the context of a comprehensive person-centered rehabilitation program. Furthermore, active goal setting for specific spasticity interventions is also important, with a well-established \u201cmore is better\u201d approach. It is critical to consider adjunctive therapy and multimodal approaches if patients are not attaining their treatment goals. Often used interchangeably, there may be confusion between the terms adjunctive and multimodal therapy. Yet it is imperative to understand the differences between these approaches to achieve treatment goals in spasticity management. Addition of a secondary pharmacologic or non-pharmacologic treatment to optimize the efficacy of the initial modality, such as adding electrical stimulation or casting to BoNT-A, is considered an adjunctive therapy. Adjunctive therapy is time-specific and requires the added therapy be initiated within a specific period to enhance the primary treatment; usually within 2\u2009weeks. Multimodal therapy is an integrated, patient-centric program of pharmacologic and non-pharmacologic strategies utilized in a concurrent\/integrated or sequential manner to enhance the overall treatment effect across a variety of spasticity-associated impairments (e.g., neural and non-neural components). Moreover, within a multimodal approach, adjunctive therapy can be used to help enhance the treatment effect of one specific modality. The objectives of this paper are to clarify the differences between adjunctive and multimodal therapies, provide a brief evidence-based review of such approaches, and highlight clinical insights on selecting multimodal and adjunctive therapies in spasticity management.<\/jats:p>","DOI":"10.3389\/fneur.2024.1432330","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:46:36Z","timestamp":1724978796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Multimodal therapy and use of adjunctive therapies to BoNT-A in spasticity management: defining terminology to help enhance spasticity treatment"],"prefix":"10.3389","volume":"15","author":[{"given":"Rajiv","family":"Reebye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Jorge","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Balbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Carda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Draulans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"O\u2019Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Picelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Santamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Verduzco-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Wissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard E.","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"ref1","volume-title":"Spasticity in adults: management using botulinum toxin. National guidelines","year":"2018"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.23736\/S1973-9087.17.04808-0","article-title":"A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework","volume":"54","author":"Turner-Stokes","year":"2018","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.rehab.2021.101544","article-title":"Adjunct therapies after botulinum toxin injections in spastic adults. Systematic review and SOFMER recommendations","volume":"65","author":"Allart","year":"2022","journal-title":"Ann Phys Rehabil Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/0269215515593783","article-title":"Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity","volume":"30","author":"Mills","year":"2016","journal-title":"Clin Rehabil"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.rehab.2018.08.004","article-title":"Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature","volume":"62","author":"Picelli","year":"2019","journal-title":"Ann Phys Rehabil Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-1331.2010.03125.x","article-title":"International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments \u2013 introduction","volume":"17","author":"Esquenazi","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/mus.20284","article-title":"Pathophysiology of spastic paresis. I: paresis and soft tissue changes","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/0269215519831337","article-title":"Effectiveness of a programme comprising serial casting, botulinum toxin, splinting and motor training for contracture management: a randomized controlled trial","volume":"33","author":"Leung","year":"2019","journal-title":"Clin Rehabil"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1080\/02699052.2018.1469044","article-title":"Therapy influences goal attainment following botulinum neurotoxin injection for focal spasticity in adults with neurological conditions","volume":"32","author":"Moore","year":"2018","journal-title":"Brain Inj"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1468-1331.2002.0090s1048.x","article-title":"A summary of spasticity management \u2013 a treatment algorithm","volume":"9","author":"Ward","year":"2002","journal-title":"Eur J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4103\/2349-7904.347807","article-title":"Module 1: pathophysiology and assessment of spasticity; goal setting","volume":"5","author":"Escaldi","year":"2022","journal-title":"JISPRM"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/toxins15120676","article-title":"Selecting goals and target muscles for botulinum toxin a injection using the goal oriented facilitated approach to spasticity treatment (GO-FAST) tool","volume":"15","author":"Jacinto","year":"2023","journal-title":"Toxins (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2340\/16501977-0303","article-title":"European consensus table on use of botulinum toxin a in adult spasticity","volume":"41","author":"Wissel","year":"2009","journal-title":"J Rehabil Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4103\/1658-354X.121087","article-title":"Spasticity - pathogenesis, prevention and treatment strategies","volume":"7","author":"Ghai","year":"2013","journal-title":"Saudi J Anaesth"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1743-0003-10-81","article-title":"Differentiation between non-neural and neural contributors to ankle joint stiffness in cerebral palsy","volume":"10","author":"Gooijer-Van De Groep","year":"2013","journal-title":"J Neuroeng Rehabil"},{"key":"ref16","first-page":"253","article-title":"Use of botulinum toxin type a in the management of patients with neurological disorders: a national survey","volume":"28","author":"Smania","year":"2013","journal-title":"Funct Neurol"},{"key":"ref17","first-page":"525","article-title":"Management of stroke patients submitted to botulinum toxin type a therapy: a Delphi survey of an Italian expert panel of specialist injectors","volume":"50","author":"Franceschini","year":"2014","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.rehab.2017.10.001","article-title":"Non-pharmacological interventions for spasticity in adults: an overview of systematic reviews","volume":"62","author":"Khan","year":"2019","journal-title":"Ann Phys Rehabil Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.rehab.2017.10.001","article-title":"Rehabilitation procedures in the management of spasticity","volume":"46","author":"Smania","year":"2010","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref20","first-page":"759","article-title":"Combined effects of robot-assisted gait training and botulinum toxin type a on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial","volume":"52","author":"Picelli","year":"2016","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.4103\/2349-7904.347808","article-title":"Module 2: nonsurgical management of spasticity","volume":"5","author":"Reebye","year":"2022","journal-title":"J Int Soc Phys Rehabil Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"jrm00005","DOI":"10.2340\/16501977-2629","article-title":"Does casting after botulinum toxin injection improve outcomes in adults with limb spasticity? A systematic review","volume":"52","author":"Farag","year":"2020","journal-title":"Rehabil Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"jrm00134","DOI":"10.2340\/16501977-2753","article-title":"A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin a: an international group consensus","volume":"53","author":"Francisco","year":"2021","journal-title":"J Rehabil Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/pmrj.12442","article-title":"Practice patterns of physicians using adjunct therapies with botulinum toxin injection for spasticity: a Canadian multicenter cross-sectional survey","volume":"13","author":"Ip","year":"2021","journal-title":"PMR"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"jrm00320","DOI":"10.2340\/jrm.v54.334","article-title":"Worldwide survey of clinician practice on use of adjunctive therapies following botulinum toxin injection for spasticity","volume":"54","author":"Schillebeeckx","year":"2022","journal-title":"J Rehabil Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"jrm00110","DOI":"10.2340\/16501977-2743","article-title":"Effect of treating elbow flexor spasticity with botulinum toxin injection and adjunctive casting on hemiparetic gait parameters: a prospective case series","volume":"52","author":"Kotteduwa Jayawarden","year":"2020","journal-title":"J Rehabil Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/toxins16020098","article-title":"Best practice guidelines for the Management of Patients with post-stroke spasticity: a modified scoping review","volume":"16","author":"Suputtitada","year":"2024","journal-title":"Toxins (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.apmr.2018.10.016","article-title":"Effects of transcutaneous electrical nerve stimulation on spasticity in adults with stroke. A systematic review and meta analysis","volume":"100","author":"Mahmood","year":"2019","journal-title":"Arch Phys Med Rehabil"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/pmrj.13106","article-title":"Multidisciplinary collaborative consensus statement on the barriers and solutions to care access, patient and caregiver support, and clinical capacity and capability for patients with spasticity","volume":"16","author":"Patel","year":"2024","journal-title":"PMR"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/STROKEAHA.109.558619","article-title":"Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event","volume":"41","author":"Lundstr\u00f6m","year":"2010","journal-title":"Stroke"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/03007995.2018.1447449","article-title":"A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom","volume":"34","author":"Raluy-Callado","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13561-016-0107-5","article-title":"Quality of life and costs of spasticity treatment in German stroke patients","volume":"6","author":"Rychlik","year":"2016","journal-title":"Heal Econ Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jocn.2017.02.044","article-title":"Breakthroughs in the spasticity management: are non-pharmacological treatments the future?","volume":"39","author":"Naro","year":"2017","journal-title":"J Clin Neurosci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.pmrj.2017.03.014","article-title":"Spasticity management: the current state of transcranial neuromodulation","volume":"9","author":"Leo","year":"2017","journal-title":"PMR"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1161\/strokeaha.123.043159","article-title":"Evidence of rTMS for motor or cognitive stroke recovery: hype or Hope?","volume":"54","author":"Hofmeijer","year":"2023","journal-title":"Stroke"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1197422","DOI":"10.3389\/fimmu.2023.1197422","article-title":"Repetitive transcranial magnetic stimulation for stroke rehabilitation: insights into the molecular and cellular mechanisms of neuroinflammation","volume":"14","author":"Sheng","year":"2023","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3390\/jcm12072601","article-title":"Transcranial direct current stimulation for chronic stroke: is neuroimaging the answer to the next leap forward?","volume":"12","author":"Salazar","year":"2023","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"CD006876","DOI":"10.1002\/14651858.CD006876.pub4","article-title":"Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke","volume":"2015","author":"Mehrholz","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref39","author":"Emos","year":"2024"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1432330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T07:50:17Z","timestamp":1727941817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1432330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":39,"alternative-id":["10.3389\/fneur.2024.1432330"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1432330","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"article-number":"1432330"}}